Cargando…
Switchable immune modulator for tumor-specific activation of anticancer immunity
Immune stimulatory antibodies and cytokines elicit potent antitumor immunity. However, the dose-limiting systemic toxicity greatly hinders their clinical applications. Here, we demonstrate a chemical approach, termed “switchable” immune modulator (Sw-IM), to limit the systemic exposure and therefore...
Autores principales: | Zhao, Yu, Xie, Yu-Qing, Van Herck, Simon, Nassiri, Sina, Gao, Min, Guo, Yugang, Tang, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442900/ https://www.ncbi.nlm.nih.gov/pubmed/34516776 http://dx.doi.org/10.1126/sciadv.abg7291 |
Ejemplares similares
-
Small-molecule PIK-93 modulates the tumor microenvironment to improve immune checkpoint blockade response
por: Lin, Chia-Yi, et al.
Publicado: (2023) -
An ultrasound-driven immune-boosting molecular machine for systemic tumor suppression
por: Wang, Liu, et al.
Publicado: (2021) -
Lef1 restricts ectopic crypt formation and tumor cell growth in intestinal adenomas
por: Heino, Sarika, et al.
Publicado: (2021) -
Active recruitment of anti–PD-1–conjugated platelets through tumor-selective thrombosis for enhanced anticancer immunotherapy
por: Wang, Yixin, et al.
Publicado: (2023) -
Tumor-associated nonmyelinating Schwann cell–expressed PVT1 promotes pancreatic cancer kynurenine pathway and tumor immune exclusion
por: Sun, Chengcao, et al.
Publicado: (2023)